| CRP reduction (mg/dl) (Mean ± SD) | ESR reduction (mm/1st hour) (Mean ± SD) | Duration (months) (Mean ± SD) | |
|---|---|---|---|
| 1st DMARD therapies | -1.3 ± 3.4 | -10.5 ± 27.5 | 24.5 ± 27.7 |
| 2nd DMARD therapies | -0.6 ± 2.8 | -5.7 ± 23.9 | 20.4 ± 23.7 |
| 3rd DMARD therapies | -0.3 ± 2.5 | -4.7 ± 20.8 | 19.8 ± 22.0 |
| 4th DMARD therapies | -0.9 ± 2.1 | -6.9 ± 26.8 | 18.6 ± 20.3 |
| >4th DMARD therapies | 0.1 ± 2.5 | -0.7 ± 25.1 | 14.6 ± 20.9 |
Acute Phase Response and Duration of Consecutive DMARD Therapies.